Overview

Comparison of Brimonidine Purite, Dorzolamide, and Brinzolamide as Adjunctive Therapy to Prostaglandin Analogs

Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the efficacy of brimonidine Purite, dorzolamide, and brinzolamide in reducing intraocular pressure when added to prostaglandin analog therapy (bimatoprost, latanoprost, or travoprost) in patients with glaucoma or ocular hypertension.
Phase:
Phase 4
Details
Lead Sponsor:
Northwestern Ophthalmic Institute S.C.
Collaborator:
Research to Prevent Blindness
Treatments:
Brimonidine Tartrate
Brinzolamide
Dorzolamide
Ophthalmic Solutions